Celldex Therapeutics, Inc. (FRA:TCE2)

Celldex Therapeutics Revenue

Celldex Therapeutics had revenue of $2.60M USD in the twelve months ending September 30, 2025, down -73.94% year-over-year. In the year 2024, Celldex Therapeutics had annual revenue of $7.02M with 1.99% growth.

• Revenue (ttm): $2.60M
• Revenue Growth: -73.94%
• P/S Ratio: 668.85
• Revenue / Employee: $13.98K
• Employees: 186
• Market Cap: 1.48B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.02M	137.00K	1.99%
Dec 31, 2023	6.88M	4.53M	192.02%
Dec 31, 2022	2.36M	-2.29M	-49.32%
Dec 31, 2021	4.65M	-2.77M	-37.30%
Dec 31, 2020	7.42M	3.85M	107.61%
Dec 31, 2019	3.57M	-5.97M	-62.54%
Dec 31, 2018	9.54M	-3.21M	-25.15%
Dec 31, 2017	12.74M	5.96M	87.78%
Dec 31, 2016	6.79M	1.31M	23.83%
Dec 31, 2015	5.48M	1.89M	52.82%
Dec 31, 2014	3.59M	-525.00K	-12.77%
Dec 31, 2013	4.11M	-7.09M	-63.30%
Dec 31, 2012	11.20M	1.94M	20.91%
Dec 31, 2011	9.27M	-37.53M	-80.20%
Dec 31, 2010	46.79M	31.61M	208.25%
Dec 31, 2009	15.18M	7.72M	103.59%
Dec 31, 2008	7.46M	6.05M	430.30%
Dec 31, 2007	1.41M	506.82K	56.36%
Dec 31, 2006	899.18K	-2.19M	-70.88%
Dec 31, 2005	3.09M	-	-